Budesonide Capsules Versus Mesalazine Granules in Active Ulcerative Colitis (UC)

Clinical trial NCT00747110 · COMPLETED

Trial details

NCT number: NCT00747110
Sponsor: Dr. Falk Pharma GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Colitis, Ulcerative

Start date: 2007-10-01
Primary completion: 2008-08-01
Enrollment: 343

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.